Person
Gregg W. Stone
Topic
All Topics
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Gregg W. Stone
... endpoint of infarct size in patients with large myocardial infarction," said Gregg W. Stone, MD, principal investigator of the IC-HOT study and professor of medicine ...
... BRS Landscape: Where do we Stand? (ABSORB, MAGNITUDE, DESolve, FANTOM, and DREAMS-2G)Gregg W. Stone, MD, New York-Presbyterian Hospital/Columbia University Medical Center, New York, NY, USA ...
... additional viable treatments to help this large population of patients," said Gregg Stone, MD, Co-Principal Investigator of the CALM 2 trial and director of cardiovascular ...
... the field of transcatheter valve therapy. Martin B. Leon, MD and Gregg W. Stone, MD, two of TVT's course directors, will moderate the 1-hour session ...
... to confidently expand their use of the product in their patients. Dr. Gregg Stone from the Columbia University Medical Center and the Cardiovascular Research Foundation ...
... Kamakura General Hospital, Kamakura City, Japan, and U.S. National Principal Investigator, Gregg W. Stone, MD, of New York-Presbyterian Hospital/Columbia University Medical Center, New York, NY. ...
... Richard A. Shlofmitz of St. Francis Hospital in Roslyn, N.Y.; and Dr. Gregg Stone, Columbia University Medical Center, N.Y. COAST 1-year outcomes as compared to ...
... lack of response significantly increases their risk of further complications," said Gregg Stone, MD, Co-Principal Investigator of the CALM II worldwide clinical trial and director ...
... randomized to angiography-guided PCI alone versus angiography and OCT-guided PCI," said Dr. Gregg W. Stone, professor of medicine at Columbia University, director of cardiovascular research ...
... Antithrombotic Therapy: The Experts Take Sides," with Kenneth Mahaffey, MD and Gregg W. Stone, MD during the session on Dyslipidemia, Atherosclerosis and Cardiovascular Disease Risk ...
... seen numerous approaches to controlling resistant hypertension over the years," said Gregg W. Stone, MD, Director of Cardiovascular Research and Education at Columbia University Medical ...
... its Scientific Advisory Council which already includes thought leaders such as Dr. Gregg Stone, Dr. Azfar Zaman, Dr. Adrian Banning, Dr. Malte Kelm, Dr. Tienush ...
... outcomes, especially in patients with large ST-segment elevation MI (STEMI)," stated Dr. Gregg W. Stone, Professor of Medicine at Columbia University College and Director of ...
... sold is all Absorb had to prove, said another study leader, Dr. Gregg Stone of Columbia University Medical Center. "The question is what does it ...
... sold is all Absorb had to prove, said another study leader, Dr. Gregg Stone of Columbia University Medical Center. "The question is what does it ...
... and Catheterization Laboratories at Shonan Kamakura General Hospital, Kamakura, Japan and Dr. Gregg Stone, Director of the Cardiovascular Research and Education Center for Interventional Vascular ...
... Heart and Vessel Center in Essen, Germany (to commence in August 2015);Gregg W. Stone, MD, FACC, FSCAI; Professor of Medicine at the Columbia University Medical ...
... affects many heart patients. ''Half the people over 65 have blockages,'' Dr. Gregg W. Stone, an interventional cardiologist at Columbia, said. ''If you have some ...
... technique, imaging, and pharmacotherapy have been nothing short of amazing." - Dr. Gregg Stone, Columbia University Medical Center, New York, New York "It has been ...
... therapy for PCI in ACS, and STEMI patients in particular," said Gregg W. Stone, MD, Director, Cardiovascular Research and Education, Columbia University Medical Center/New York ...
... reductions in risk for cardiac death and major non-CABG bleeding," said Gregg W. Stone, MD, Professor of Medicine at Columbia University College of Physicians and ...
... trial effort to evaluate this technology." Osprey Medical also announced that Dr. Gregg Stone will serve as Chairman of the AVERT Trial's Steering Committee, which ...
... option for further reducing infarct size in heart attack patients," said Gregg W. Stone, MD, principal investigator of the SSO2 Therapy IDE trial and professor ...
... conducted at 70 sites in the U.S. and Europe, will be Gregg Stone, MD, of the Cardiovascular Research Foundation in New York and Jose P.S. ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤